• Price Momentum

    TRLV is trading near the top of its 52-week range and above its 200-day simple moving average.

  • Price change

    The price of TRLV shares has increased $0.66 since the market last closed. This is a 6.06% rise.

  • Closed at $11.56.

    The stock has since risen $0.04 in after-hours trading.

Key terms

About TRLV

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
  • Market cap: $2.23B

    A market capitalization between $2 billion and $10 billion places TRLV in the mid-capitalization category.

Key terms

Smart score

Latest TRLV news

Today 3:35am ET Canaccord Genuity Sticks to Its Buy Rating for Trulieve Cannabis (TRLV) Nov 06, 2026 9:48am ET Trulieve Cannabis (TRLV) Gets a Buy from Roth MKM Nov 06, 2026 9:41am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Nov 05, 2026 6:58am ET Trulieve Reports Strong Third-Quarter Financial Results and Cash Flow Nov 05, 2026 6:53am ET Trulieve Cannabis reports Q3 adjusted EPS 9c, consensus 7c Nov 03, 2026 7:59am ET Cantor Fitzgerald Sticks to Their Buy Rating for Trulieve Cannabis (TRLV) Nov 02, 2026 9:21am ET Trulieve Cannabis receives registrations for medical marijuana dispensaries Oct 23, 2026 9:19am ET Cantor Fitzgerald Remains a Buy on Trulieve Cannabis (TRLV) Oct 07, 2026 8:11am ET Trulieve Cannabis repays $65M mortgage, reduces debt to $225M Oct 06, 2026 9:49am ET Trulieve Sets Date for Q3 2026 Results Call as It Expands U.S. Medical Cannabis Footprint Oct 05, 2026 9:30am ET Analysts Offer Insights on Healthcare Companies: Trulieve Cannabis (TRLV) and Enovis (ENOV) Sep 30, 2026 12:05pm ET Trulieve Cannabis falls -16.0% Sep 30, 2026 10:10am ET DEA judge pauses marijuana rescheduling hearing Sep 30, 2026 10:00am ET Trulieve Cannabis falls -13.1% Sep 30, 2026 9:16am ET Cantor Fitzgerald Reaffirms Their Buy Rating on Trulieve Cannabis (TRLV) Sep 28, 2026 9:15am ET Trulieve Expands Exclusive Alien Labs and Connected Licensing to Florida and Texas Sep 28, 2026 8:07am ET Trulieve Cannabis announces licensing deal with Connected Sep 04, 2026 9:07am ET Trulieve Expands Georgia Presence With New Dunwoody Medical Cannabis Dispensary Sep 02, 2026 9:07am ET Trulieve to Step Up Investor Outreach With September Conference Appearances Aug 25, 2026 8:45am ET Largest borrow rate increases among liquid names Aug 16, 2026 9:17am ET Largest borrow rate increases among liquid names Aug 11, 2026 4:28pm ET Trulieve Cannabis Completes Delaware Corporate Domestication Move Aug 11, 2026 4:16pm ET Trulieve Cannabis completes redomicile from British Columbia to Delaware Aug 10, 2026 8:13pm ET Trulieve Cannabis Earnings Call Highlights Margin Strength

No recent press releases are available for TRLV

TRLV Financials

1-year income & revenue

  • Total revenue: $1.18B (1Y), $230.22M (Q3)

    Total Revenue held flat since last year and decreased 15.03% since last quarter.

  • Net income: -$116.38M (1Y), $869.00K (Q3)

    Net Income increased 24.97% since last year and increased 100.21% since last quarter.

  • Earnings per share: -$0.61 (1Y), $0.00 (Q3)

    EPS increased 25.49% since last year and increased 100.2% since last quarter.

Key terms

TRLV Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TRLV Competitors

$ Market capP/E ratio$ Price1d change52-week range
  • How competitors are chosen

    TRLV's competitors are included in the Process Industries sector and Agricultural Commodities/Milling group

  • Market cap: $2.23B

    A market capitalization between $2 billion and $10 billion places TRLV in the mid-capitalization category.

Key terms